Removal of Drugs for Alzheimer ’s Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA)

ConclusionThis study provides real-life information about the use of AD drugs after they were withdrawn from reimbursement in France and shows that drug discontinuation was limited among patients followed in memory centres and accompanied by increased use of other healthcare resources.

http://link.springer.com/10.1007/s40266-020-00817-3

Source: Drugs and Aging - January 7, 2021 Category: Geriatrics Source Type: research